nodes	percent_of_prediction	percent_of_DWPC	metapath
Oxandrolone—AR—hematologic cancer	0.48	1	CbGaD
Oxandrolone—Danazol—Prednisone—hematologic cancer	0.0427	0.145	CrCrCtD
Oxandrolone—Fluoxymesterone—Betamethasone—hematologic cancer	0.0346	0.118	CrCrCtD
Oxandrolone—Fluoxymesterone—Dexamethasone—hematologic cancer	0.0346	0.118	CrCrCtD
Oxandrolone—Fluoxymesterone—Triamcinolone—hematologic cancer	0.0338	0.115	CrCrCtD
Oxandrolone—Fluoxymesterone—Prednisolone—hematologic cancer	0.0314	0.106	CrCrCtD
Oxandrolone—Progesterone—Prednisolone—hematologic cancer	0.0305	0.104	CrCrCtD
Oxandrolone—Methyltestosterone—Prednisone—hematologic cancer	0.0305	0.104	CrCrCtD
Oxandrolone—Methyltestosterone—Prednisolone—hematologic cancer	0.0298	0.101	CrCrCtD
Oxandrolone—Testosterone—Prednisolone—hematologic cancer	0.0265	0.09	CrCrCtD
Oxandrolone—Stanozolol—AR—hematologic cancer	0.000572	0.126	CrCbGaD
Oxandrolone—Menstruation irregular—Prednisolone—hematologic cancer	0.000517	0.00319	CcSEcCtD
Oxandrolone—Fluid retention—Nilotinib—hematologic cancer	0.000516	0.00318	CcSEcCtD
Oxandrolone—Acne—Bortezomib—hematologic cancer	0.000515	0.00318	CcSEcCtD
Oxandrolone—Fluid retention—Imatinib—hematologic cancer	0.000513	0.00316	CcSEcCtD
Oxandrolone—Neoplasm—Chlorambucil—hematologic cancer	0.000502	0.0031	CcSEcCtD
Oxandrolone—Irritability—Clofarabine—hematologic cancer	0.000495	0.00305	CcSEcCtD
Oxandrolone—Hirsutism—Prednisolone—hematologic cancer	0.000493	0.00304	CcSEcCtD
Oxandrolone—Neoplasm—Nilotinib—hematologic cancer	0.000491	0.00303	CcSEcCtD
Oxandrolone—Neoplasm—Imatinib—hematologic cancer	0.000489	0.00301	CcSEcCtD
Oxandrolone—Creatinine increased—Hydroxyurea—hematologic cancer	0.000488	0.00301	CcSEcCtD
Oxandrolone—Gynaecomastia—Nilotinib—hematologic cancer	0.000486	0.003	CcSEcCtD
Oxandrolone—Blood creatinine increased—Clofarabine—hematologic cancer	0.000486	0.003	CcSEcCtD
Oxandrolone—Blood creatinine increased—Pentostatin—hematologic cancer	0.000484	0.00298	CcSEcCtD
Oxandrolone—Blood creatinine increased—Anagrelide—hematologic cancer	0.000484	0.00298	CcSEcCtD
Oxandrolone—Gynaecomastia—Imatinib—hematologic cancer	0.000483	0.00298	CcSEcCtD
Oxandrolone—Neoplasm—Cladribine—hematologic cancer	0.00048	0.00296	CcSEcCtD
Oxandrolone—Necrosis—Carmustine—hematologic cancer	0.000478	0.00295	CcSEcCtD
Oxandrolone—Haemoglobin—Lomustine—hematologic cancer	0.000477	0.00294	CcSEcCtD
Oxandrolone—Menstruation irregular—Triamcinolone—hematologic cancer	0.000476	0.00293	CcSEcCtD
Oxandrolone—Haemorrhage—Lomustine—hematologic cancer	0.000475	0.00293	CcSEcCtD
Oxandrolone—Necrosis—Ifosfamide—hematologic cancer	0.000468	0.00289	CcSEcCtD
Oxandrolone—AR—Notch-mediated HES/HEY network—PARP1—hematologic cancer	0.000465	0.00795	CbGpPWpGaD
Oxandrolone—Acne—Thalidomide—hematologic cancer	0.000465	0.00286	CcSEcCtD
Oxandrolone—Neoplasm—Vinblastine—hematologic cancer	0.00046	0.00284	CcSEcCtD
Oxandrolone—AR—SIDS Susceptibility Pathways—TCF3—hematologic cancer	0.000459	0.00785	CbGpPWpGaD
Oxandrolone—Haemoglobin—Mechlorethamine—hematologic cancer	0.000457	0.00282	CcSEcCtD
Oxandrolone—Haemorrhage—Mechlorethamine—hematologic cancer	0.000455	0.0028	CcSEcCtD
Oxandrolone—Hirsutism—Triamcinolone—hematologic cancer	0.000453	0.00279	CcSEcCtD
Oxandrolone—AR—Regulation of nuclear SMAD2/3 signaling—RUNX3—hematologic cancer	0.000445	0.00762	CbGpPWpGaD
Oxandrolone—Jaundice cholestatic—Thalidomide—hematologic cancer	0.000445	0.00274	CcSEcCtD
Oxandrolone—Necrosis—Mitoxantrone—hematologic cancer	0.000445	0.00274	CcSEcCtD
Oxandrolone—Creatinine increased—Vinorelbine—hematologic cancer	0.000445	0.00274	CcSEcCtD
Oxandrolone—Acne—Alitretinoin—hematologic cancer	0.000442	0.00273	CcSEcCtD
Oxandrolone—AR—Androgen receptor signaling pathway—NCOR2—hematologic cancer	0.000438	0.0075	CbGpPWpGaD
Oxandrolone—Neoplasm—Melphalan—hematologic cancer	0.000438	0.0027	CcSEcCtD
Oxandrolone—Menstruation irregular—Betamethasone—hematologic cancer	0.000431	0.00266	CcSEcCtD
Oxandrolone—Menstruation irregular—Dexamethasone—hematologic cancer	0.000431	0.00266	CcSEcCtD
Oxandrolone—Neoplasm—Lenalidomide—hematologic cancer	0.000426	0.00263	CcSEcCtD
Oxandrolone—AR—SIDS Susceptibility Pathways—GATA2—hematologic cancer	0.000423	0.00724	CbGpPWpGaD
Oxandrolone—Gynaecomastia—Lenalidomide—hematologic cancer	0.000421	0.0026	CcSEcCtD
Oxandrolone—Blood creatinine increased—Busulfan—hematologic cancer	0.000421	0.00259	CcSEcCtD
Oxandrolone—Neoplasm—Hydroxyurea—hematologic cancer	0.00042	0.00259	CcSEcCtD
Oxandrolone—AR—Androgen receptor signaling pathway—SUMO1—hematologic cancer	0.000413	0.00706	CbGpPWpGaD
Oxandrolone—Fluid retention—Bortezomib—hematologic cancer	0.000411	0.00254	CcSEcCtD
Oxandrolone—Hirsutism—Betamethasone—hematologic cancer	0.000411	0.00253	CcSEcCtD
Oxandrolone—Hirsutism—Dexamethasone—hematologic cancer	0.000411	0.00253	CcSEcCtD
Oxandrolone—Erectile dysfunction—Pentostatin—hematologic cancer	0.000411	0.00253	CcSEcCtD
Oxandrolone—Erectile dysfunction—Anagrelide—hematologic cancer	0.000411	0.00253	CcSEcCtD
Oxandrolone—Creatinine increased—Thalidomide—hematologic cancer	0.000411	0.00253	CcSEcCtD
Oxandrolone—Necrosis—Cisplatin—hematologic cancer	0.000404	0.00249	CcSEcCtD
Oxandrolone—Blood creatinine increased—Dasatinib—hematologic cancer	0.0004	0.00247	CcSEcCtD
Oxandrolone—Blood creatinine increased—Bexarotene—hematologic cancer	0.0004	0.00247	CcSEcCtD
Oxandrolone—Neoplasm—Bortezomib—hematologic cancer	0.000392	0.00242	CcSEcCtD
Oxandrolone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—DKK1—hematologic cancer	0.000391	0.00669	CbGpPWpGaD
Oxandrolone—Fluid retention—Thiotepa—hematologic cancer	0.000384	0.00237	CcSEcCtD
Oxandrolone—AR—Regulation of Androgen receptor activity—HSP90AA1—hematologic cancer	0.000378	0.00648	CbGpPWpGaD
Oxandrolone—AR—Coregulation of Androgen receptor activity—CDK6—hematologic cancer	0.000377	0.00645	CbGpPWpGaD
Oxandrolone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—ADCY7—hematologic cancer	0.000377	0.00645	CbGpPWpGaD
Oxandrolone—Menstruation irregular—Prednisone—hematologic cancer	0.000376	0.00232	CcSEcCtD
Oxandrolone—AR—SIDS Susceptibility Pathways—RET—hematologic cancer	0.000374	0.0064	CbGpPWpGaD
Oxandrolone—AR—Nuclear Receptors—NR3C1—hematologic cancer	0.000373	0.00638	CbGpPWpGaD
Oxandrolone—Danazol—CCL2—hematologic cancer	0.000371	0.082	CrCbGaD
Oxandrolone—Necrosis—Etoposide—hematologic cancer	0.00037	0.00228	CcSEcCtD
Oxandrolone—Blood creatinine increased—Nilotinib—hematologic cancer	0.00037	0.00228	CcSEcCtD
Oxandrolone—Blood creatinine increased—Imatinib—hematologic cancer	0.000367	0.00227	CcSEcCtD
Oxandrolone—Haemoglobin—Clofarabine—hematologic cancer	0.000361	0.00222	CcSEcCtD
Oxandrolone—Haemoglobin—Anagrelide—hematologic cancer	0.000359	0.00221	CcSEcCtD
Oxandrolone—Haemoglobin—Pentostatin—hematologic cancer	0.000359	0.00221	CcSEcCtD
Oxandrolone—Haemorrhage—Clofarabine—hematologic cancer	0.000359	0.00221	CcSEcCtD
Oxandrolone—Hirsutism—Prednisone—hematologic cancer	0.000358	0.00221	CcSEcCtD
Oxandrolone—Erectile dysfunction—Busulfan—hematologic cancer	0.000357	0.0022	CcSEcCtD
Oxandrolone—Haemorrhage—Pentostatin—hematologic cancer	0.000357	0.0022	CcSEcCtD
Oxandrolone—Haemorrhage—Anagrelide—hematologic cancer	0.000357	0.0022	CcSEcCtD
Oxandrolone—Creatinine increased—Gemcitabine—hematologic cancer	0.000357	0.0022	CcSEcCtD
Oxandrolone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—SMARCA4—hematologic cancer	0.000357	0.00611	CbGpPWpGaD
Oxandrolone—AR—Generic Transcription Pathway—ZNF552—hematologic cancer	0.000354	0.00605	CbGpPWpGaD
Oxandrolone—Gynaecomastia—Thalidomide—hematologic cancer	0.00035	0.00216	CcSEcCtD
Oxandrolone—Haemoglobin—Idarubicin—hematologic cancer	0.000346	0.00214	CcSEcCtD
Oxandrolone—AR—Androgen receptor signaling pathway—NCOA3—hematologic cancer	0.000346	0.00592	CbGpPWpGaD
Oxandrolone—Haemorrhage—Idarubicin—hematologic cancer	0.000345	0.00212	CcSEcCtD
Oxandrolone—Drostanolone—AR—hematologic cancer	0.000343	0.0757	CrCbGaD
Oxandrolone—AR—Notch-mediated HES/HEY network—HES1—hematologic cancer	0.000342	0.00585	CbGpPWpGaD
Oxandrolone—Acne—Prednisolone—hematologic cancer	0.00034	0.0021	CcSEcCtD
Oxandrolone—Erectile dysfunction—Bexarotene—hematologic cancer	0.00034	0.0021	CcSEcCtD
Oxandrolone—AR—Notch-mediated HES/HEY network—NCOR1—hematologic cancer	0.00034	0.00581	CbGpPWpGaD
Oxandrolone—Neoplasm—Carmustine—hematologic cancer	0.000339	0.00209	CcSEcCtD
Oxandrolone—Haemoglobin—Teniposide—hematologic cancer	0.000337	0.00208	CcSEcCtD
Oxandrolone—Gynaecomastia—Carmustine—hematologic cancer	0.000336	0.00207	CcSEcCtD
Oxandrolone—AR—Nongenotropic Androgen signaling—FOS—hematologic cancer	0.000335	0.00574	CbGpPWpGaD
Oxandrolone—Haemorrhage—Teniposide—hematologic cancer	0.000335	0.00207	CcSEcCtD
Oxandrolone—AR—Nongenotropic Androgen signaling—CREB1—hematologic cancer	0.000335	0.00573	CbGpPWpGaD
Oxandrolone—Neoplasm—Ifosfamide—hematologic cancer	0.000332	0.00205	CcSEcCtD
Oxandrolone—Fluid retention—Gemcitabine—hematologic cancer	0.000323	0.00199	CcSEcCtD
Oxandrolone—Blood creatinine increased—Lenalidomide—hematologic cancer	0.00032	0.00197	CcSEcCtD
Oxandrolone—AR—Integrated Pancreatic Cancer Pathway—TOP1—hematologic cancer	0.000318	0.00544	CbGpPWpGaD
Oxandrolone—AR—Integrated Breast Cancer Pathway—ATR—hematologic cancer	0.000318	0.00544	CbGpPWpGaD
Oxandrolone—AR—Regulation of nuclear SMAD2/3 signaling—GATA3—hematologic cancer	0.000317	0.00543	CbGpPWpGaD
Oxandrolone—AR—Nuclear Receptors—ESR1—hematologic cancer	0.000316	0.00541	CbGpPWpGaD
Oxandrolone—Blood creatinine increased—Hydroxyurea—hematologic cancer	0.000316	0.00195	CcSEcCtD
Oxandrolone—Neoplasm—Irinotecan—hematologic cancer	0.000316	0.00195	CcSEcCtD
Oxandrolone—Erectile dysfunction—Nilotinib—hematologic cancer	0.000314	0.00194	CcSEcCtD
Oxandrolone—Acne—Triamcinolone—hematologic cancer	0.000313	0.00193	CcSEcCtD
Oxandrolone—Erectile dysfunction—Imatinib—hematologic cancer	0.000312	0.00193	CcSEcCtD
Oxandrolone—Haemoglobin—Busulfan—hematologic cancer	0.000312	0.00192	CcSEcCtD
Oxandrolone—AR—Nongenotropic Androgen signaling—MAP2K1—hematologic cancer	0.000311	0.00533	CbGpPWpGaD
Oxandrolone—Haemorrhage—Busulfan—hematologic cancer	0.000311	0.00192	CcSEcCtD
Oxandrolone—Necrosis—Dexamethasone—hematologic cancer	0.000304	0.00188	CcSEcCtD
Oxandrolone—Necrosis—Betamethasone—hematologic cancer	0.000304	0.00188	CcSEcCtD
Oxandrolone—Haemoglobin—Procarbazine—hematologic cancer	0.000303	0.00187	CcSEcCtD
Oxandrolone—Haemorrhage—Procarbazine—hematologic cancer	0.000301	0.00186	CcSEcCtD
Oxandrolone—Fluid retention—Cisplatin—hematologic cancer	0.000301	0.00185	CcSEcCtD
Oxandrolone—AR—Regulation of Androgen receptor activity—FOXO1—hematologic cancer	0.000301	0.00515	CbGpPWpGaD
Oxandrolone—Irritability—Bortezomib—hematologic cancer	0.0003	0.00185	CcSEcCtD
Oxandrolone—Haemoglobin—Bexarotene—hematologic cancer	0.000297	0.00183	CcSEcCtD
Oxandrolone—Haemoglobin—Dasatinib—hematologic cancer	0.000297	0.00183	CcSEcCtD
Oxandrolone—Haemoglobin—Fludarabine—hematologic cancer	0.000296	0.00183	CcSEcCtD
Oxandrolone—Haemorrhage—Bexarotene—hematologic cancer	0.000295	0.00182	CcSEcCtD
Oxandrolone—Haemorrhage—Dasatinib—hematologic cancer	0.000295	0.00182	CcSEcCtD
Oxandrolone—Haemorrhage—Fludarabine—hematologic cancer	0.000295	0.00182	CcSEcCtD
Oxandrolone—AR—Nuclear Receptor transcription pathway—NR3C1—hematologic cancer	0.000294	0.00504	CbGpPWpGaD
Oxandrolone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—HDAC2—hematologic cancer	0.000293	0.00501	CbGpPWpGaD
Oxandrolone—Testosterone Propionate—UGT1A1—hematologic cancer	0.000292	0.0646	CrCbGaD
Oxandrolone—AR—Nongenotropic Androgen signaling—PIK3R1—hematologic cancer	0.000292	0.005	CbGpPWpGaD
Oxandrolone—AR—Regulation of nuclear SMAD2/3 signaling—HDAC2—hematologic cancer	0.00029	0.00496	CbGpPWpGaD
Oxandrolone—Blood creatinine increased—Vinorelbine—hematologic cancer	0.000288	0.00177	CcSEcCtD
Oxandrolone—AR—Regulation of Androgen receptor activity—NR3C1—hematologic cancer	0.000285	0.00489	CbGpPWpGaD
Oxandrolone—Acne—Betamethasone—hematologic cancer	0.000284	0.00175	CcSEcCtD
Oxandrolone—Acne—Dexamethasone—hematologic cancer	0.000284	0.00175	CcSEcCtD
Oxandrolone—Allylestrenol—ESR1—hematologic cancer	0.000284	0.0628	CrCbGaD
Oxandrolone—AR—Androgen receptor signaling pathway—CALR—hematologic cancer	0.000284	0.00485	CbGpPWpGaD
Oxandrolone—AR—Integrated Pancreatic Cancer Pathway—RARA—hematologic cancer	0.000283	0.00485	CbGpPWpGaD
Oxandrolone—AR—FOXA1 transcription factor network—ESR1—hematologic cancer	0.000281	0.00481	CbGpPWpGaD
Oxandrolone—Trilostane—ESR1—hematologic cancer	0.000277	0.0612	CrCbGaD
Oxandrolone—Blood creatinine increased—Thiotepa—hematologic cancer	0.000275	0.00169	CcSEcCtD
Oxandrolone—Haemoglobin—Nilotinib—hematologic cancer	0.000274	0.00169	CcSEcCtD
Oxandrolone—Haemorrhage—Nilotinib—hematologic cancer	0.000273	0.00168	CcSEcCtD
Oxandrolone—Haemoglobin—Imatinib—hematologic cancer	0.000273	0.00168	CcSEcCtD
Oxandrolone—Oedema—Nelarabine—hematologic cancer	0.000272	0.00168	CcSEcCtD
Oxandrolone—Erectile dysfunction—Lenalidomide—hematologic cancer	0.000272	0.00168	CcSEcCtD
Oxandrolone—Fluid retention—Prednisolone—hematologic cancer	0.000272	0.00168	CcSEcCtD
Oxandrolone—Haemorrhage—Imatinib—hematologic cancer	0.000271	0.00167	CcSEcCtD
Oxandrolone—Haemoglobin—Cladribine—hematologic cancer	0.000268	0.00165	CcSEcCtD
Oxandrolone—Haemorrhage—Cladribine—hematologic cancer	0.000267	0.00164	CcSEcCtD
Oxandrolone—Oedema—Methoxsalen—hematologic cancer	0.000266	0.00164	CcSEcCtD
Oxandrolone—Blood creatinine increased—Thalidomide—hematologic cancer	0.000266	0.00164	CcSEcCtD
Oxandrolone—Necrosis—Prednisone—hematologic cancer	0.000265	0.00163	CcSEcCtD
Oxandrolone—AR—SIDS Susceptibility Pathways—RUNX3—hematologic cancer	0.000263	0.00451	CbGpPWpGaD
Oxandrolone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CCND2—hematologic cancer	0.000261	0.00447	CbGpPWpGaD
Oxandrolone—AR—Integrated Breast Cancer Pathway—NF1—hematologic cancer	0.000259	0.00444	CbGpPWpGaD
Oxandrolone—Oedema—Mercaptopurine—hematologic cancer	0.000258	0.00159	CcSEcCtD
Oxandrolone—AR—Notch-mediated HES/HEY network—NOTCH1—hematologic cancer	0.000258	0.00441	CbGpPWpGaD
Oxandrolone—Irritability—Alitretinoin—hematologic cancer	0.000258	0.00159	CcSEcCtD
Oxandrolone—Haemoglobin—Vinblastine—hematologic cancer	0.000257	0.00158	CcSEcCtD
Oxandrolone—Haemorrhage—Vinblastine—hematologic cancer	0.000256	0.00158	CcSEcCtD
Oxandrolone—AR—SIDS Susceptibility Pathways—HDAC9—hematologic cancer	0.000255	0.00437	CbGpPWpGaD
Oxandrolone—Oedema—Daunorubicin—hematologic cancer	0.000255	0.00157	CcSEcCtD
Oxandrolone—Oedema—Clofarabine—hematologic cancer	0.000255	0.00157	CcSEcCtD
Oxandrolone—Oedema—Anagrelide—hematologic cancer	0.000254	0.00157	CcSEcCtD
Oxandrolone—AR—FOXA1 transcription factor network—FOS—hematologic cancer	0.000253	0.00434	CbGpPWpGaD
Oxandrolone—Blood creatinine increased—Alitretinoin—hematologic cancer	0.000253	0.00156	CcSEcCtD
Oxandrolone—AR—SIDS Susceptibility Pathways—FOXM1—hematologic cancer	0.000253	0.00432	CbGpPWpGaD
Oxandrolone—Erectile dysfunction—Bortezomib—hematologic cancer	0.00025	0.00154	CcSEcCtD
Oxandrolone—Fluid retention—Triamcinolone—hematologic cancer	0.00025	0.00154	CcSEcCtD
Oxandrolone—Blood creatinine increased—Ifosfamide—hematologic cancer	0.00025	0.00154	CcSEcCtD
Oxandrolone—AR—Nuclear Receptor transcription pathway—ESR1—hematologic cancer	0.00025	0.00428	CbGpPWpGaD
Oxandrolone—Acne—Prednisone—hematologic cancer	0.000247	0.00152	CcSEcCtD
Oxandrolone—AR—Regulation of Androgen receptor activity—MAPK14—hematologic cancer	0.000247	0.00423	CbGpPWpGaD
Oxandrolone—AR—FOXA1 transcription factor network—CREBBP—hematologic cancer	0.000247	0.00422	CbGpPWpGaD
Oxandrolone—Insomnia—Nelarabine—hematologic cancer	0.000246	0.00152	CcSEcCtD
Oxandrolone—Haemoglobin—Melphalan—hematologic cancer	0.000244	0.00151	CcSEcCtD
Oxandrolone—Haemorrhage—Melphalan—hematologic cancer	0.000243	0.0015	CcSEcCtD
Oxandrolone—AR—SIDS Susceptibility Pathways—MYB—hematologic cancer	0.000243	0.00416	CbGpPWpGaD
Oxandrolone—Insomnia—Methoxsalen—hematologic cancer	0.000241	0.00148	CcSEcCtD
Oxandrolone—Oedema—Teniposide—hematologic cancer	0.000238	0.00147	CcSEcCtD
Oxandrolone—Haemoglobin—Lenalidomide—hematologic cancer	0.000238	0.00147	CcSEcCtD
Oxandrolone—Blood creatinine increased—Irinotecan—hematologic cancer	0.000237	0.00146	CcSEcCtD
Oxandrolone—Blood creatinine increased—Mitoxantrone—hematologic cancer	0.000237	0.00146	CcSEcCtD
Oxandrolone—Haemorrhage—Lenalidomide—hematologic cancer	0.000237	0.00146	CcSEcCtD
Oxandrolone—AR—Integrated Pancreatic Cancer Pathway—BBC3—hematologic cancer	0.000235	0.00402	CbGpPWpGaD
Oxandrolone—Haemoglobin—Hydroxyurea—hematologic cancer	0.000234	0.00145	CcSEcCtD
Oxandrolone—AR—Notch-mediated HES/HEY network—CREBBP—hematologic cancer	0.000234	0.004	CbGpPWpGaD
Oxandrolone—Haemorrhage—Hydroxyurea—hematologic cancer	0.000233	0.00144	CcSEcCtD
Oxandrolone—AR—Notch-mediated HES/HEY network—RB1—hematologic cancer	0.000233	0.00399	CbGpPWpGaD
Oxandrolone—AR—Regulation of nuclear SMAD2/3 signaling—CDKN2B—hematologic cancer	0.000232	0.00397	CbGpPWpGaD
Oxandrolone—Blood creatinine increased—Gemcitabine—hematologic cancer	0.000231	0.00143	CcSEcCtD
Oxandrolone—Insomnia—Daunorubicin—hematologic cancer	0.000231	0.00142	CcSEcCtD
Oxandrolone—Insomnia—Anagrelide—hematologic cancer	0.00023	0.00142	CcSEcCtD
Oxandrolone—Insomnia—Pentostatin—hematologic cancer	0.00023	0.00142	CcSEcCtD
Oxandrolone—Fluid retention—Betamethasone—hematologic cancer	0.000227	0.0014	CcSEcCtD
Oxandrolone—Fluid retention—Dexamethasone—hematologic cancer	0.000227	0.0014	CcSEcCtD
Oxandrolone—AR—Integrated Breast Cancer Pathway—NCOA3—hematologic cancer	0.000227	0.00388	CbGpPWpGaD
Oxandrolone—Erectile dysfunction—Thalidomide—hematologic cancer	0.000226	0.00139	CcSEcCtD
Oxandrolone—Necrosis—Methotrexate—hematologic cancer	0.000222	0.00137	CcSEcCtD
Oxandrolone—Oedema—Busulfan—hematologic cancer	0.000221	0.00136	CcSEcCtD
Oxandrolone—AR—Regulation of nuclear SMAD2/3 signaling—NCOR1—hematologic cancer	0.00022	0.00376	CbGpPWpGaD
Oxandrolone—AR—Regulation of nuclear SMAD2/3 signaling—IL10—hematologic cancer	0.00022	0.00376	CbGpPWpGaD
Oxandrolone—Irritability—Cisplatin—hematologic cancer	0.00022	0.00135	CcSEcCtD
Oxandrolone—Haemoglobin—Bortezomib—hematologic cancer	0.000219	0.00135	CcSEcCtD
Oxandrolone—Haemorrhage—Bortezomib—hematologic cancer	0.000218	0.00134	CcSEcCtD
Oxandrolone—Haemoglobin—Bleomycin—hematologic cancer	0.000217	0.00134	CcSEcCtD
Oxandrolone—AR—Nongenotropic Androgen signaling—SRC—hematologic cancer	0.000216	0.0037	CbGpPWpGaD
Oxandrolone—Haemorrhage—Bleomycin—hematologic cancer	0.000216	0.00133	CcSEcCtD
Oxandrolone—Blood creatinine increased—Cisplatin—hematologic cancer	0.000215	0.00133	CcSEcCtD
Oxandrolone—AR—Integrated Breast Cancer Pathway—PML—hematologic cancer	0.000215	0.00368	CbGpPWpGaD
Oxandrolone—AR—Integrated Breast Cancer Pathway—SMARCA4—hematologic cancer	0.000215	0.00368	CbGpPWpGaD
Oxandrolone—AR—Regulation of nuclear SMAD2/3 signaling—FOXO1—hematologic cancer	0.000214	0.00367	CbGpPWpGaD
Oxandrolone—Oedema—Procarbazine—hematologic cancer	0.000214	0.00132	CcSEcCtD
Oxandrolone—AR—Regulation of Androgen receptor activity—CREBBP—hematologic cancer	0.000212	0.00364	CbGpPWpGaD
Oxandrolone—AR—Integrated Pancreatic Cancer Pathway—JUND—hematologic cancer	0.000211	0.0036	CbGpPWpGaD
Oxandrolone—Oedema—Dasatinib—hematologic cancer	0.00021	0.00129	CcSEcCtD
Oxandrolone—Oedema—Bexarotene—hematologic cancer	0.00021	0.00129	CcSEcCtD
Oxandrolone—Oedema—Fludarabine—hematologic cancer	0.000209	0.00129	CcSEcCtD
Oxandrolone—Testosterone Propionate—AR—hematologic cancer	0.000209	0.0462	CrCbGaD
Oxandrolone—AR—SIDS Susceptibility Pathways—IL13—hematologic cancer	0.000208	0.00356	CbGpPWpGaD
Oxandrolone—Necrosis—Epirubicin—hematologic cancer	0.000207	0.00128	CcSEcCtD
Oxandrolone—Erectile dysfunction—Vincristine—hematologic cancer	0.000207	0.00128	CcSEcCtD
Oxandrolone—Haemoglobin—Thiotepa—hematologic cancer	0.000204	0.00126	CcSEcCtD
Oxandrolone—AR—Androgen receptor signaling pathway—NCOR1—hematologic cancer	0.000204	0.00349	CbGpPWpGaD
Oxandrolone—AR—Notch-mediated HES/HEY network—JAK2—hematologic cancer	0.000203	0.00348	CbGpPWpGaD
Oxandrolone—AR—Regulation of nuclear SMAD2/3 signaling—NR3C1—hematologic cancer	0.000203	0.00348	CbGpPWpGaD
Oxandrolone—Haemorrhage—Thiotepa—hematologic cancer	0.000203	0.00125	CcSEcCtD
Oxandrolone—Erectile dysfunction—Mitoxantrone—hematologic cancer	0.000202	0.00124	CcSEcCtD
Oxandrolone—AR—Integrated Pancreatic Cancer Pathway—WT1—hematologic cancer	0.0002	0.00342	CbGpPWpGaD
Oxandrolone—Insomnia—Busulfan—hematologic cancer	0.0002	0.00123	CcSEcCtD
Oxandrolone—AR—Nongenotropic Androgen signaling—MAPK3—hematologic cancer	0.000199	0.00341	CbGpPWpGaD
Oxandrolone—AR—Androgen receptor signaling pathway—FOXO1—hematologic cancer	0.000199	0.0034	CbGpPWpGaD
Oxandrolone—Fluid retention—Prednisone—hematologic cancer	0.000198	0.00122	CcSEcCtD
Oxandrolone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—TERT—hematologic cancer	0.000196	0.00335	CbGpPWpGaD
Oxandrolone—Oedema—Nilotinib—hematologic cancer	0.000194	0.0012	CcSEcCtD
Oxandrolone—Insomnia—Procarbazine—hematologic cancer	0.000194	0.00119	CcSEcCtD
Oxandrolone—Fluoxymesterone—AR—hematologic cancer	0.000194	0.0428	CrCbGaD
Oxandrolone—AR—Notch-mediated HES/HEY network—CD4—hematologic cancer	0.000193	0.0033	CbGpPWpGaD
Oxandrolone—Oedema—Imatinib—hematologic cancer	0.000193	0.00119	CcSEcCtD
Oxandrolone—Necrosis—Doxorubicin—hematologic cancer	0.000192	0.00118	CcSEcCtD
Oxandrolone—AR—FOXA1 transcription factor network—CDKN1B—hematologic cancer	0.000191	0.00327	CbGpPWpGaD
Oxandrolone—AR—Coregulation of Androgen receptor activity—CASP8—hematologic cancer	0.000191	0.00326	CbGpPWpGaD
Oxandrolone—Insomnia—Dasatinib—hematologic cancer	0.00019	0.00117	CcSEcCtD
Oxandrolone—Insomnia—Bexarotene—hematologic cancer	0.00019	0.00117	CcSEcCtD
Oxandrolone—Haemoglobin—Carmustine—hematologic cancer	0.000189	0.00117	CcSEcCtD
Oxandrolone—Oedema—Cladribine—hematologic cancer	0.000189	0.00117	CcSEcCtD
Oxandrolone—AR—Integrated Pancreatic Cancer Pathway—CST3—hematologic cancer	0.000189	0.00324	CbGpPWpGaD
Oxandrolone—Haemorrhage—Carmustine—hematologic cancer	0.000189	0.00116	CcSEcCtD
Oxandrolone—Haemoglobin—Alitretinoin—hematologic cancer	0.000188	0.00116	CcSEcCtD
Oxandrolone—AR—SIDS Susceptibility Pathways—GATA3—hematologic cancer	0.000188	0.00321	CbGpPWpGaD
Oxandrolone—Haemorrhage—Alitretinoin—hematologic cancer	0.000187	0.00115	CcSEcCtD
Oxandrolone—Haemoglobin—Ifosfamide—hematologic cancer	0.000186	0.00114	CcSEcCtD
Oxandrolone—Jaundice cholestatic—Epirubicin—hematologic cancer	0.000185	0.00114	CcSEcCtD
Oxandrolone—Danazol—AR—hematologic cancer	0.000185	0.0409	CrCbGaD
Oxandrolone—Haemorrhage—Ifosfamide—hematologic cancer	0.000185	0.00114	CcSEcCtD
Oxandrolone—AR—Regulation of nuclear SMAD2/3 signaling—CDK2—hematologic cancer	0.000183	0.00314	CbGpPWpGaD
Oxandrolone—AR—FOXA1 transcription factor network—JUN—hematologic cancer	0.000182	0.00312	CbGpPWpGaD
Oxandrolone—AR—Notch-mediated HES/HEY network—CDKN1B—hematologic cancer	0.000181	0.0031	CbGpPWpGaD
Oxandrolone—AR—Regulation of Androgen receptor activity—MDM2—hematologic cancer	0.00018	0.00309	CbGpPWpGaD
Oxandrolone—AR—Integrated Pancreatic Cancer Pathway—PML—hematologic cancer	0.000178	0.00305	CbGpPWpGaD
Oxandrolone—Spironolactone—AR—hematologic cancer	0.000177	0.0392	CrCbGaD
Oxandrolone—Haemoglobin—Irinotecan—hematologic cancer	0.000176	0.00109	CcSEcCtD
Oxandrolone—Haemoglobin—Mitoxantrone—hematologic cancer	0.000176	0.00109	CcSEcCtD
Oxandrolone—Insomnia—Nilotinib—hematologic cancer	0.000175	0.00108	CcSEcCtD
Oxandrolone—Haemorrhage—Irinotecan—hematologic cancer	0.000175	0.00108	CcSEcCtD
Oxandrolone—Haemorrhage—Mitoxantrone—hematologic cancer	0.000175	0.00108	CcSEcCtD
Oxandrolone—Insomnia—Imatinib—hematologic cancer	0.000174	0.00108	CcSEcCtD
Oxandrolone—AR—Regulation of nuclear SMAD2/3 signaling—CDK4—hematologic cancer	0.000173	0.00297	CbGpPWpGaD
Oxandrolone—Oedema—Melphalan—hematologic cancer	0.000173	0.00107	CcSEcCtD
Oxandrolone—AR—Regulation of nuclear SMAD2/3 signaling—ESR1—hematologic cancer	0.000173	0.00295	CbGpPWpGaD
Oxandrolone—Haemoglobin—Gemcitabine—hematologic cancer	0.000172	0.00106	CcSEcCtD
Oxandrolone—Jaundice cholestatic—Doxorubicin—hematologic cancer	0.000171	0.00106	CcSEcCtD
Oxandrolone—Insomnia—Cladribine—hematologic cancer	0.000171	0.00106	CcSEcCtD
Oxandrolone—Creatinine increased—Epirubicin—hematologic cancer	0.000171	0.00105	CcSEcCtD
Oxandrolone—Haemorrhage—Gemcitabine—hematologic cancer	0.000171	0.00105	CcSEcCtD
Oxandrolone—AR—Gene Expression—ZNF552—hematologic cancer	0.00017	0.00291	CbGpPWpGaD
Oxandrolone—Oedema—Lenalidomide—hematologic cancer	0.000168	0.00104	CcSEcCtD
Oxandrolone—AR—FOXA1 transcription factor network—EP300—hematologic cancer	0.000168	0.00287	CbGpPWpGaD
Oxandrolone—AR—Coregulation of Androgen receptor activity—CDKN2A—hematologic cancer	0.000166	0.00285	CbGpPWpGaD
Oxandrolone—Oedema—Hydroxyurea—hematologic cancer	0.000166	0.00102	CcSEcCtD
Oxandrolone—Irritability—Dexamethasone—hematologic cancer	0.000166	0.00102	CcSEcCtD
Oxandrolone—Irritability—Betamethasone—hematologic cancer	0.000166	0.00102	CcSEcCtD
Oxandrolone—AR—Nongenotropic Androgen signaling—PIK3CA—hematologic cancer	0.000164	0.00281	CbGpPWpGaD
Oxandrolone—AR—Integrated Pancreatic Cancer Pathway—TOP2A—hematologic cancer	0.000163	0.00279	CbGpPWpGaD
Oxandrolone—AR—Integrated Pancreatic Cancer Pathway—CASP7—hematologic cancer	0.000162	0.00277	CbGpPWpGaD
Oxandrolone—AR—Notch-mediated HES/HEY network—EP300—hematologic cancer	0.000159	0.00273	CbGpPWpGaD
Oxandrolone—Creatinine increased—Doxorubicin—hematologic cancer	0.000158	0.000975	CcSEcCtD
Oxandrolone—AR—Integrated Breast Cancer Pathway—STAT1—hematologic cancer	0.000158	0.0027	CbGpPWpGaD
Oxandrolone—Neoplasm—Methotrexate—hematologic cancer	0.000157	0.000969	CcSEcCtD
Oxandrolone—AR—Regulation of Androgen receptor activity—JUN—hematologic cancer	0.000157	0.00268	CbGpPWpGaD
Oxandrolone—Methyltestosterone—AR—hematologic cancer	0.000156	0.0346	CrCbGaD
Oxandrolone—AR—Regulation of nuclear SMAD2/3 signaling—FOS—hematologic cancer	0.000156	0.00266	CbGpPWpGaD
Oxandrolone—Gynaecomastia—Methotrexate—hematologic cancer	0.000156	0.000959	CcSEcCtD
Oxandrolone—AR—Regulation of nuclear SMAD2/3 signaling—CREB1—hematologic cancer	0.000155	0.00266	CbGpPWpGaD
Oxandrolone—Oedema—Bortezomib—hematologic cancer	0.000155	0.000953	CcSEcCtD
Oxandrolone—AR—Integrated Pancreatic Cancer Pathway—EZH2—hematologic cancer	0.000155	0.00265	CbGpPWpGaD
Oxandrolone—Fluid retention—Epirubicin—hematologic cancer	0.000154	0.000953	CcSEcCtD
Oxandrolone—Oedema—Bleomycin—hematologic cancer	0.000153	0.000946	CcSEcCtD
Oxandrolone—AR—Nongenotropic Androgen signaling—HRAS—hematologic cancer	0.000152	0.0026	CbGpPWpGaD
Oxandrolone—Insomnia—Lenalidomide—hematologic cancer	0.000152	0.000937	CcSEcCtD
Oxandrolone—AR—Regulation of nuclear SMAD2/3 signaling—CREBBP—hematologic cancer	0.000151	0.00259	CbGpPWpGaD
Oxandrolone—AR—Notch-mediated HES/HEY network—STAT3—hematologic cancer	0.000149	0.00256	CbGpPWpGaD
Oxandrolone—Fluoxymesterone—ESR1—hematologic cancer	0.000149	0.033	CrCbGaD
Oxandrolone—AR—Regulation of Androgen receptor activity—MAPK8—hematologic cancer	0.000148	0.00254	CbGpPWpGaD
Oxandrolone—Neoplasm—Epirubicin—hematologic cancer	0.000147	0.000907	CcSEcCtD
Oxandrolone—AR—Regulation of Androgen receptor activity—EP300—hematologic cancer	0.000145	0.00248	CbGpPWpGaD
Oxandrolone—Haemoglobin—Prednisolone—hematologic cancer	0.000145	0.000891	CcSEcCtD
Oxandrolone—Irritability—Prednisone—hematologic cancer	0.000144	0.000889	CcSEcCtD
Oxandrolone—AR—Androgen receptor signaling pathway—CREB1—hematologic cancer	0.000144	0.00247	CbGpPWpGaD
Oxandrolone—Haemorrhage—Prednisolone—hematologic cancer	0.000144	0.000887	CcSEcCtD
Oxandrolone—Fluid retention—Doxorubicin—hematologic cancer	0.000143	0.000881	CcSEcCtD
Oxandrolone—Danazol—ESR1—hematologic cancer	0.000142	0.0315	CrCbGaD
Oxandrolone—AR—Integrated Breast Cancer Pathway—ABL1—hematologic cancer	0.000142	0.00243	CbGpPWpGaD
Oxandrolone—AR—Generic Transcription Pathway—RARA—hematologic cancer	0.000141	0.00241	CbGpPWpGaD
Oxandrolone—AR—Integrated Pancreatic Cancer Pathway—IL3—hematologic cancer	0.000141	0.00241	CbGpPWpGaD
Oxandrolone—AR—Regulation of Androgen receptor activity—SRC—hematologic cancer	0.000141	0.00241	CbGpPWpGaD
Oxandrolone—AR—Coregulation of Androgen receptor activity—CCND1—hematologic cancer	0.00014	0.0024	CbGpPWpGaD
Oxandrolone—AR—Androgen receptor signaling pathway—CREBBP—hematologic cancer	0.00014	0.0024	CbGpPWpGaD
Oxandrolone—Insomnia—Bortezomib—hematologic cancer	0.00014	0.000862	CcSEcCtD
Oxandrolone—AR—Androgen receptor signaling pathway—RB1—hematologic cancer	0.00014	0.00239	CbGpPWpGaD
Oxandrolone—Oedema—Thalidomide—hematologic cancer	0.000139	0.00086	CcSEcCtD
Oxandrolone—Neoplasm—Doxorubicin—hematologic cancer	0.000136	0.000839	CcSEcCtD
Oxandrolone—AR—Nongenotropic Androgen signaling—AKT1—hematologic cancer	0.000134	0.0023	CbGpPWpGaD
Oxandrolone—Oedema—Carmustine—hematologic cancer	0.000134	0.000826	CcSEcCtD
Oxandrolone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CDKN2A—hematologic cancer	0.000134	0.00229	CbGpPWpGaD
Oxandrolone—Haemoglobin—Triamcinolone—hematologic cancer	0.000133	0.000819	CcSEcCtD
Oxandrolone—Oedema—Alitretinoin—hematologic cancer	0.000133	0.000818	CcSEcCtD
Oxandrolone—Haemorrhage—Triamcinolone—hematologic cancer	0.000132	0.000815	CcSEcCtD
Oxandrolone—Fluoxymesterone—NR3C1—hematologic cancer	0.000131	0.029	CrCbGaD
Oxandrolone—Oedema—Ifosfamide—hematologic cancer	0.000131	0.000809	CcSEcCtD
Oxandrolone—AR—Generic Transcription Pathway—NR0B2—hematologic cancer	0.000131	0.00224	CbGpPWpGaD
Oxandrolone—AR—Integrated Pancreatic Cancer Pathway—STAT1—hematologic cancer	0.000131	0.00224	CbGpPWpGaD
Oxandrolone—AR—SIDS Susceptibility Pathways—HES1—hematologic cancer	0.000131	0.00224	CbGpPWpGaD
Oxandrolone—AR—Integrated Breast Cancer Pathway—BAX—hematologic cancer	0.00013	0.00223	CbGpPWpGaD
Oxandrolone—AR—Integrated Breast Cancer Pathway—FOXO1—hematologic cancer	0.00013	0.00223	CbGpPWpGaD
Oxandrolone—AR—SIDS Susceptibility Pathways—IL10—hematologic cancer	0.00013	0.00223	CbGpPWpGaD
Oxandrolone—AR—Gene Expression—CASC3—hematologic cancer	0.000129	0.00221	CbGpPWpGaD
Oxandrolone—Oedema—Vincristine—hematologic cancer	0.000128	0.000788	CcSEcCtD
Oxandrolone—AR—Integrated Breast Cancer Pathway—JAK1—hematologic cancer	0.000127	0.00218	CbGpPWpGaD
Oxandrolone—Insomnia—Thalidomide—hematologic cancer	0.000126	0.000778	CcSEcCtD
Oxandrolone—AR—Androgen receptor signaling pathway—PIK3R1—hematologic cancer	0.000126	0.00215	CbGpPWpGaD
Oxandrolone—Oedema—Mitoxantrone—hematologic cancer	0.000125	0.000768	CcSEcCtD
Oxandrolone—Oedema—Irinotecan—hematologic cancer	0.000125	0.000768	CcSEcCtD
Oxandrolone—AR—Integrated Pancreatic Cancer Pathway—GRB2—hematologic cancer	0.000122	0.0021	CbGpPWpGaD
Oxandrolone—AR—Integrated Pancreatic Cancer Pathway—PDGFA—hematologic cancer	0.000122	0.00209	CbGpPWpGaD
Oxandrolone—Oedema—Gemcitabine—hematologic cancer	0.000121	0.000748	CcSEcCtD
Oxandrolone—Insomnia—Carmustine—hematologic cancer	0.000121	0.000747	CcSEcCtD
Oxandrolone—Haemoglobin—Betamethasone—hematologic cancer	0.000121	0.000744	CcSEcCtD
Oxandrolone—Haemoglobin—Dexamethasone—hematologic cancer	0.000121	0.000744	CcSEcCtD
Oxandrolone—Irritability—Methotrexate—hematologic cancer	0.00012	0.000743	CcSEcCtD
Oxandrolone—AR—SIDS Susceptibility Pathways—NR3C1—hematologic cancer	0.00012	0.00206	CbGpPWpGaD
Oxandrolone—Erectile dysfunction—Prednisone—hematologic cancer	0.00012	0.000741	CcSEcCtD
Oxandrolone—Spironolactone—NR3C1—hematologic cancer	0.00012	0.0266	CrCbGaD
Oxandrolone—Insomnia—Alitretinoin—hematologic cancer	0.00012	0.00074	CcSEcCtD
Oxandrolone—Haemorrhage—Betamethasone—hematologic cancer	0.00012	0.00074	CcSEcCtD
Oxandrolone—Haemorrhage—Dexamethasone—hematologic cancer	0.00012	0.00074	CcSEcCtD
Oxandrolone—AR—Androgen receptor signaling pathway—MDM2—hematologic cancer	0.000119	0.00204	CbGpPWpGaD
Oxandrolone—AR—Generic Transcription Pathway—NCOR2—hematologic cancer	0.000118	0.00202	CbGpPWpGaD
Oxandrolone—AR—Integrated Pancreatic Cancer Pathway—STAT5A—hematologic cancer	0.000118	0.00201	CbGpPWpGaD
Oxandrolone—AR—Integrated Pancreatic Cancer Pathway—ABL1—hematologic cancer	0.000118	0.00201	CbGpPWpGaD
Oxandrolone—AR—Integrated Pancreatic Cancer Pathway—CDKN2B—hematologic cancer	0.000117	0.002	CbGpPWpGaD
Oxandrolone—Insomnia—Vincristine—hematologic cancer	0.000116	0.000713	CcSEcCtD
Oxandrolone—AR—Integrated Pancreatic Cancer Pathway—ABCB1—hematologic cancer	0.000114	0.00195	CbGpPWpGaD
Oxandrolone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CCND1—hematologic cancer	0.000113	0.00194	CbGpPWpGaD
Oxandrolone—Oedema—Cisplatin—hematologic cancer	0.000113	0.000697	CcSEcCtD
Oxandrolone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—JUN—hematologic cancer	0.000113	0.00193	CbGpPWpGaD
Oxandrolone—Insomnia—Irinotecan—hematologic cancer	0.000113	0.000694	CcSEcCtD
Oxandrolone—AR—Integrated Breast Cancer Pathway—TSC2—hematologic cancer	0.000112	0.00192	CbGpPWpGaD
Oxandrolone—AR—Regulation of nuclear SMAD2/3 signaling—JUN—hematologic cancer	0.000112	0.00191	CbGpPWpGaD
Oxandrolone—AR—Integrated Breast Cancer Pathway—CDK2—hematologic cancer	0.000111	0.00191	CbGpPWpGaD
Oxandrolone—Blood creatinine increased—Epirubicin—hematologic cancer	0.000111	0.000682	CcSEcCtD
Oxandrolone—Insomnia—Gemcitabine—hematologic cancer	0.00011	0.000676	CcSEcCtD
Oxandrolone—AR—Integrated Pancreatic Cancer Pathway—FGF1—hematologic cancer	0.000109	0.00187	CbGpPWpGaD
Oxandrolone—AR—Regulation of nuclear SMAD2/3 signaling—CDKN1A—hematologic cancer	0.000108	0.00185	CbGpPWpGaD
Oxandrolone—Progesterone—SLC22A1—hematologic cancer	0.000108	0.0239	CrCbGaD
Oxandrolone—AR—Integrated Pancreatic Cancer Pathway—BAX—hematologic cancer	0.000108	0.00185	CbGpPWpGaD
Oxandrolone—AR—Integrated Pancreatic Cancer Pathway—PDGFRA—hematologic cancer	0.000106	0.00181	CbGpPWpGaD
Oxandrolone—AR—Integrated Breast Cancer Pathway—ATM—hematologic cancer	0.000106	0.00181	CbGpPWpGaD
Oxandrolone—AR—Integrated Breast Cancer Pathway—CDK4—hematologic cancer	0.000105	0.0018	CbGpPWpGaD
Oxandrolone—Haemoglobin—Prednisone—hematologic cancer	0.000105	0.000647	CcSEcCtD
Oxandrolone—AR—Integrated Breast Cancer Pathway—ESR1—hematologic cancer	0.000105	0.0018	CbGpPWpGaD
Oxandrolone—Haemorrhage—Prednisone—hematologic cancer	0.000104	0.000644	CcSEcCtD
Oxandrolone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—EP300—hematologic cancer	0.000104	0.00178	CbGpPWpGaD
Oxandrolone—AR—Androgen receptor signaling pathway—CCND1—hematologic cancer	0.000104	0.00178	CbGpPWpGaD
Oxandrolone—AR—Androgen receptor signaling pathway—JUN—hematologic cancer	0.000104	0.00177	CbGpPWpGaD
Oxandrolone—AR—Regulation of nuclear SMAD2/3 signaling—EP300—hematologic cancer	0.000103	0.00176	CbGpPWpGaD
Oxandrolone—AR—Integrated Pancreatic Cancer Pathway—FASLG—hematologic cancer	0.000103	0.00176	CbGpPWpGaD
Oxandrolone—Blood creatinine increased—Doxorubicin—hematologic cancer	0.000102	0.000631	CcSEcCtD
Oxandrolone—AR—Integrated Breast Cancer Pathway—BAD—hematologic cancer	0.000102	0.00175	CbGpPWpGaD
Oxandrolone—Oedema—Prednisolone—hematologic cancer	0.000102	0.00063	CcSEcCtD
Oxandrolone—Testosterone—SLC22A1—hematologic cancer	0.000102	0.0226	CrCbGaD
Oxandrolone—Erectile dysfunction—Methotrexate—hematologic cancer	0.0001	0.00062	CcSEcCtD
Oxandrolone—AR—Androgen receptor signaling pathway—CDKN1A—hematologic cancer	0.0001	0.00172	CbGpPWpGaD
Oxandrolone—AR—Androgen receptor signaling pathway—PTEN—hematologic cancer	0.0001	0.00172	CbGpPWpGaD
Oxandrolone—AR—Integrated Pancreatic Cancer Pathway—FAS—hematologic cancer	9.92e-05	0.0017	CbGpPWpGaD
Oxandrolone—Progesterone—AR—hematologic cancer	9.59e-05	0.0212	CrCbGaD
Oxandrolone—AR—Androgen receptor signaling pathway—EP300—hematologic cancer	9.56e-05	0.00164	CbGpPWpGaD
Oxandrolone—AR—Integrated Breast Cancer Pathway—CREB1—hematologic cancer	9.44e-05	0.00162	CbGpPWpGaD
Oxandrolone—Oedema—Triamcinolone—hematologic cancer	9.39e-05	0.000579	CcSEcCtD
Oxandrolone—AR—Integrated Breast Cancer Pathway—BRAF—hematologic cancer	9.32e-05	0.0016	CbGpPWpGaD
Oxandrolone—AR—Androgen receptor signaling pathway—SRC—hematologic cancer	9.29e-05	0.00159	CbGpPWpGaD
Oxandrolone—Insomnia—Prednisolone—hematologic cancer	9.24e-05	0.00057	CcSEcCtD
Oxandrolone—AR—Integrated Pancreatic Cancer Pathway—CDK2—hematologic cancer	9.23e-05	0.00158	CbGpPWpGaD
Oxandrolone—AR—Integrated Breast Cancer Pathway—CASP8—hematologic cancer	9.23e-05	0.00158	CbGpPWpGaD
Oxandrolone—AR—SIDS Susceptibility Pathways—CREB1—hematologic cancer	9.19e-05	0.00157	CbGpPWpGaD
Oxandrolone—AR—Integrated Breast Cancer Pathway—RB1—hematologic cancer	9.16e-05	0.00157	CbGpPWpGaD
Oxandrolone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—MYC—hematologic cancer	9.07e-05	0.00155	CbGpPWpGaD
Oxandrolone—Testosterone—AR—hematologic cancer	9.07e-05	0.02	CrCbGaD
Oxandrolone—AR—Regulation of nuclear SMAD2/3 signaling—MYC—hematologic cancer	8.98e-05	0.00154	CbGpPWpGaD
Oxandrolone—AR—SIDS Susceptibility Pathways—IL6R—hematologic cancer	8.97e-05	0.00154	CbGpPWpGaD
Oxandrolone—AR—Androgen receptor signaling pathway—STAT3—hematologic cancer	8.96e-05	0.00153	CbGpPWpGaD
Oxandrolone—AR—SIDS Susceptibility Pathways—CREBBP—hematologic cancer	8.96e-05	0.00153	CbGpPWpGaD
Oxandrolone—AR—Integrated Pancreatic Cancer Pathway—MAPK14—hematologic cancer	8.86e-05	0.00152	CbGpPWpGaD
Oxandrolone—Haemoglobin—Methotrexate—hematologic cancer	8.78e-05	0.000541	CcSEcCtD
Oxandrolone—AR—Integrated Pancreatic Cancer Pathway—ATM—hematologic cancer	8.76e-05	0.0015	CbGpPWpGaD
Oxandrolone—Haemorrhage—Methotrexate—hematologic cancer	8.73e-05	0.000538	CcSEcCtD
Oxandrolone—AR—Integrated Pancreatic Cancer Pathway—CDK4—hematologic cancer	8.73e-05	0.00149	CbGpPWpGaD
Oxandrolone—AR—Integrated Pancreatic Cancer Pathway—ESR1—hematologic cancer	8.69e-05	0.00149	CbGpPWpGaD
Oxandrolone—Oedema—Betamethasone—hematologic cancer	8.52e-05	0.000526	CcSEcCtD
Oxandrolone—Oedema—Dexamethasone—hematologic cancer	8.52e-05	0.000526	CcSEcCtD
Oxandrolone—Insomnia—Triamcinolone—hematologic cancer	8.5e-05	0.000524	CcSEcCtD
Oxandrolone—AR—Integrated Pancreatic Cancer Pathway—NFKBIA—hematologic cancer	8.48e-05	0.00145	CbGpPWpGaD
Oxandrolone—AR—Integrated Pancreatic Cancer Pathway—BAD—hematologic cancer	8.48e-05	0.00145	CbGpPWpGaD
Oxandrolone—AR—Gene Expression—RARS—hematologic cancer	8.31e-05	0.00142	CbGpPWpGaD
Oxandrolone—Haemoglobin—Epirubicin—hematologic cancer	8.21e-05	0.000506	CcSEcCtD
Oxandrolone—Haemorrhage—Epirubicin—hematologic cancer	8.17e-05	0.000504	CcSEcCtD
Oxandrolone—AR—Integrated Breast Cancer Pathway—BCL2—hematologic cancer	7.92e-05	0.00136	CbGpPWpGaD
Oxandrolone—AR—Integrated Pancreatic Cancer Pathway—CREB1—hematologic cancer	7.82e-05	0.00134	CbGpPWpGaD
Oxandrolone—AR—Gene Expression—POLR3E—hematologic cancer	7.82e-05	0.00134	CbGpPWpGaD
Oxandrolone—AR—Coregulation of Androgen receptor activity—AKT1—hematologic cancer	7.81e-05	0.00134	CbGpPWpGaD
Oxandrolone—AR—Integrated Breast Cancer Pathway—MDM2—hematologic cancer	7.81e-05	0.00134	CbGpPWpGaD
Oxandrolone—Insomnia—Betamethasone—hematologic cancer	7.71e-05	0.000475	CcSEcCtD
Oxandrolone—Insomnia—Dexamethasone—hematologic cancer	7.71e-05	0.000475	CcSEcCtD
Oxandrolone—AR—Integrated Pancreatic Cancer Pathway—CASP8—hematologic cancer	7.65e-05	0.00131	CbGpPWpGaD
Oxandrolone—AR—Integrated Pancreatic Cancer Pathway—CREBBP—hematologic cancer	7.62e-05	0.0013	CbGpPWpGaD
Oxandrolone—Haemoglobin—Doxorubicin—hematologic cancer	7.6e-05	0.000469	CcSEcCtD
Oxandrolone—AR—Integrated Breast Cancer Pathway—MTOR—hematologic cancer	7.6e-05	0.0013	CbGpPWpGaD
Oxandrolone—Haemorrhage—Doxorubicin—hematologic cancer	7.56e-05	0.000466	CcSEcCtD
Oxandrolone—AR—Generic Transcription Pathway—PARP1—hematologic cancer	7.52e-05	0.00129	CbGpPWpGaD
Oxandrolone—Oedema—Prednisone—hematologic cancer	7.42e-05	0.000458	CcSEcCtD
Oxandrolone—Progesterone—ESR1—hematologic cancer	7.39e-05	0.0163	CrCbGaD
Oxandrolone—AR—Integrated Pancreatic Cancer Pathway—MAP2K1—hematologic cancer	7.27e-05	0.00124	CbGpPWpGaD
Oxandrolone—Testosterone—ABCG2—hematologic cancer	7.13e-05	0.0158	CrCbGaD
Oxandrolone—AR—Integrated Breast Cancer Pathway—CASP3—hematologic cancer	6.99e-05	0.0012	CbGpPWpGaD
Oxandrolone—AR—Integrated Pancreatic Cancer Pathway—FGF2—hematologic cancer	6.92e-05	0.00118	CbGpPWpGaD
Oxandrolone—AR—SIDS Susceptibility Pathways—IL1B—hematologic cancer	6.82e-05	0.00117	CbGpPWpGaD
Oxandrolone—AR—SIDS Susceptibility Pathways—CASP3—hematologic cancer	6.81e-05	0.00117	CbGpPWpGaD
Oxandrolone—AR—Integrated Breast Cancer Pathway—CCND1—hematologic cancer	6.8e-05	0.00116	CbGpPWpGaD
Oxandrolone—AR—Integrated Breast Cancer Pathway—JUN—hematologic cancer	6.79e-05	0.00116	CbGpPWpGaD
Oxandrolone—AR—Gene Expression—TET2—hematologic cancer	6.78e-05	0.00116	CbGpPWpGaD
Oxandrolone—AR—Gene Expression—RARA—hematologic cancer	6.78e-05	0.00116	CbGpPWpGaD
Oxandrolone—Insomnia—Prednisone—hematologic cancer	6.71e-05	0.000414	CcSEcCtD
Oxandrolone—AR—Gene Expression—RPLP1—hematologic cancer	6.65e-05	0.00114	CbGpPWpGaD
Oxandrolone—AR—SIDS Susceptibility Pathways—JUN—hematologic cancer	6.61e-05	0.00113	CbGpPWpGaD
Oxandrolone—AR—Integrated Pancreatic Cancer Pathway—BCL2—hematologic cancer	6.57e-05	0.00112	CbGpPWpGaD
Oxandrolone—AR—Integrated Breast Cancer Pathway—PTEN—hematologic cancer	6.56e-05	0.00112	CbGpPWpGaD
Oxandrolone—Progesterone—NR3C1—hematologic cancer	6.5e-05	0.0144	CrCbGaD
Oxandrolone—AR—Integrated Pancreatic Cancer Pathway—MDM2—hematologic cancer	6.47e-05	0.00111	CbGpPWpGaD
Oxandrolone—AR—Gene Expression—NR0B2—hematologic cancer	6.3e-05	0.00108	CbGpPWpGaD
Oxandrolone—AR—Integrated Breast Cancer Pathway—EP300—hematologic cancer	6.26e-05	0.00107	CbGpPWpGaD
Oxandrolone—AR—Regulation of nuclear SMAD2/3 signaling—AKT1—hematologic cancer	6.23e-05	0.00107	CbGpPWpGaD
Oxandrolone—AR—SIDS Susceptibility Pathways—EP300—hematologic cancer	6.1e-05	0.00104	CbGpPWpGaD
Oxandrolone—AR—Gene Expression—DNMT3A—hematologic cancer	6.01e-05	0.00103	CbGpPWpGaD
Oxandrolone—AR—Integrated Breast Cancer Pathway—VEGFA—hematologic cancer	5.93e-05	0.00101	CbGpPWpGaD
Oxandrolone—AR—Gene Expression—ELL—hematologic cancer	5.92e-05	0.00101	CbGpPWpGaD
Oxandrolone—AR—Integrated Pancreatic Cancer Pathway—CDKN1B—hematologic cancer	5.91e-05	0.00101	CbGpPWpGaD
Oxandrolone—Oedema—Epirubicin—hematologic cancer	5.81e-05	0.000358	CcSEcCtD
Oxandrolone—Spironolactone—ABCB1—hematologic cancer	5.8e-05	0.0128	CrCbGaD
Oxandrolone—AR—Generic Transcription Pathway—CDKN2B—hematologic cancer	5.79e-05	0.000992	CbGpPWpGaD
Oxandrolone—AR—Integrated Pancreatic Cancer Pathway—CASP3—hematologic cancer	5.79e-05	0.000991	CbGpPWpGaD
Oxandrolone—AR—SIDS Susceptibility Pathways—VEGFA—hematologic cancer	5.78e-05	0.000989	CbGpPWpGaD
Oxandrolone—AR—Androgen receptor signaling pathway—AKT1—hematologic cancer	5.77e-05	0.000988	CbGpPWpGaD
Oxandrolone—AR—Gene Expression—NCOR2—hematologic cancer	5.69e-05	0.000973	CbGpPWpGaD
Oxandrolone—Norethindrone—ALB—hematologic cancer	5.64e-05	0.0125	CrCbGaD
Oxandrolone—AR—Integrated Pancreatic Cancer Pathway—CCND1—hematologic cancer	5.64e-05	0.000965	CbGpPWpGaD
Oxandrolone—AR—Integrated Pancreatic Cancer Pathway—JUN—hematologic cancer	5.62e-05	0.000963	CbGpPWpGaD
Oxandrolone—Insomnia—Methotrexate—hematologic cancer	5.61e-05	0.000346	CcSEcCtD
Oxandrolone—AR—Generic Transcription Pathway—NCOR1—hematologic cancer	5.5e-05	0.000941	CbGpPWpGaD
Oxandrolone—AR—Integrated Breast Cancer Pathway—MYC—hematologic cancer	5.46e-05	0.000934	CbGpPWpGaD
Oxandrolone—AR—Integrated Pancreatic Cancer Pathway—CDKN1A—hematologic cancer	5.45e-05	0.000933	CbGpPWpGaD
Oxandrolone—AR—Integrated Pancreatic Cancer Pathway—PTEN—hematologic cancer	5.44e-05	0.000931	CbGpPWpGaD
Oxandrolone—Norethindrone—ABCB1—hematologic cancer	5.39e-05	0.0119	CrCbGaD
Oxandrolone—Oedema—Doxorubicin—hematologic cancer	5.37e-05	0.000331	CcSEcCtD
Oxandrolone—Methyltestosterone—ALB—hematologic cancer	5.36e-05	0.0119	CrCbGaD
Oxandrolone—AR—Integrated Pancreatic Cancer Pathway—MAPK8—hematologic cancer	5.32e-05	0.000911	CbGpPWpGaD
Oxandrolone—Insomnia—Epirubicin—hematologic cancer	5.25e-05	0.000324	CcSEcCtD
Oxandrolone—AR—Gene Expression—AGO2—hematologic cancer	5.24e-05	0.000897	CbGpPWpGaD
Oxandrolone—AR—Integrated Pancreatic Cancer Pathway—EP300—hematologic cancer	5.19e-05	0.000888	CbGpPWpGaD
Oxandrolone—AR—Gene Expression—H3F3B—hematologic cancer	5.14e-05	0.000879	CbGpPWpGaD
Oxandrolone—AR—Gene Expression—DNMT3B—hematologic cancer	5.14e-05	0.000879	CbGpPWpGaD
Oxandrolone—AR—Generic Transcription Pathway—NR3C1—hematologic cancer	5.09e-05	0.00087	CbGpPWpGaD
Oxandrolone—AR—Integrated Pancreatic Cancer Pathway—SRC—hematologic cancer	5.04e-05	0.000863	CbGpPWpGaD
Oxandrolone—AR—Integrated Breast Cancer Pathway—KRAS—hematologic cancer	5.04e-05	0.000863	CbGpPWpGaD
Oxandrolone—AR—SIDS Susceptibility Pathways—TNF—hematologic cancer	4.95e-05	0.000847	CbGpPWpGaD
Oxandrolone—AR—Integrated Pancreatic Cancer Pathway—VEGFA—hematologic cancer	4.91e-05	0.000841	CbGpPWpGaD
Oxandrolone—Insomnia—Doxorubicin—hematologic cancer	4.86e-05	0.0003	CcSEcCtD
Oxandrolone—AR—Gene Expression—RPS14—hematologic cancer	4.7e-05	0.000804	CbGpPWpGaD
Oxandrolone—AR—Integrated Pancreatic Cancer Pathway—MAPK3—hematologic cancer	4.65e-05	0.000795	CbGpPWpGaD
Oxandrolone—AR—Gene Expression—NUP98—hematologic cancer	4.62e-05	0.000792	CbGpPWpGaD
Oxandrolone—AR—Integrated Pancreatic Cancer Pathway—MYC—hematologic cancer	4.52e-05	0.000774	CbGpPWpGaD
Oxandrolone—AR—Integrated Pancreatic Cancer Pathway—TGFB1—hematologic cancer	4.51e-05	0.000772	CbGpPWpGaD
Oxandrolone—AR—Integrated Breast Cancer Pathway—TP53—hematologic cancer	4.48e-05	0.000767	CbGpPWpGaD
Oxandrolone—AR—Gene Expression—NUP214—hematologic cancer	4.46e-05	0.000763	CbGpPWpGaD
Oxandrolone—AR—Generic Transcription Pathway—ESR1—hematologic cancer	4.32e-05	0.000739	CbGpPWpGaD
Oxandrolone—AR—Integrated Pancreatic Cancer Pathway—TNF—hematologic cancer	4.21e-05	0.000721	CbGpPWpGaD
Oxandrolone—AR—Integrated Pancreatic Cancer Pathway—KRAS—hematologic cancer	4.18e-05	0.000715	CbGpPWpGaD
Oxandrolone—AR—Generic Transcription Pathway—NOTCH1—hematologic cancer	4.17e-05	0.000714	CbGpPWpGaD
Oxandrolone—AR—Gene Expression—EIF4EBP1—hematologic cancer	4.11e-05	0.000703	CbGpPWpGaD
Oxandrolone—AR—Gene Expression—HSPB1—hematologic cancer	4.11e-05	0.000703	CbGpPWpGaD
Oxandrolone—AR—SIDS Susceptibility Pathways—IL6—hematologic cancer	4e-05	0.000684	CbGpPWpGaD
Oxandrolone—AR—Gene Expression—SMC1A—hematologic cancer	3.93e-05	0.000673	CbGpPWpGaD
Oxandrolone—AR—Gene Expression—H3F3A—hematologic cancer	3.85e-05	0.00066	CbGpPWpGaD
Oxandrolone—AR—Integrated Pancreatic Cancer Pathway—PIK3CA—hematologic cancer	3.84e-05	0.000657	CbGpPWpGaD
Oxandrolone—AR—Generic Transcription Pathway—CREBBP—hematologic cancer	3.78e-05	0.000648	CbGpPWpGaD
Oxandrolone—AR—Integrated Breast Cancer Pathway—AKT1—hematologic cancer	3.78e-05	0.000648	CbGpPWpGaD
Oxandrolone—AR—Integrated Pancreatic Cancer Pathway—TP53—hematologic cancer	3.71e-05	0.000635	CbGpPWpGaD
Oxandrolone—AR—Gene Expression—EZH2—hematologic cancer	3.7e-05	0.000633	CbGpPWpGaD
Oxandrolone—AR—Gene Expression—PARP1—hematologic cancer	3.62e-05	0.000619	CbGpPWpGaD
Oxandrolone—AR—Gene Expression—HDAC2—hematologic cancer	3.49e-05	0.000598	CbGpPWpGaD
Oxandrolone—Progesterone—ABCB1—hematologic cancer	3.14e-05	0.00694	CrCbGaD
Oxandrolone—AR—Integrated Pancreatic Cancer Pathway—AKT1—hematologic cancer	3.13e-05	0.000537	CbGpPWpGaD
Oxandrolone—Testosterone—ALB—hematologic cancer	3.11e-05	0.00688	CrCbGaD
Oxandrolone—Testosterone—ABCB1—hematologic cancer	2.97e-05	0.00656	CrCbGaD
Oxandrolone—AR—Gene Expression—CDKN2B—hematologic cancer	2.79e-05	0.000477	CbGpPWpGaD
Oxandrolone—AR—Gene Expression—NCOR1—hematologic cancer	2.65e-05	0.000453	CbGpPWpGaD
Oxandrolone—AR—Gene Expression—NR3C1—hematologic cancer	2.45e-05	0.000419	CbGpPWpGaD
Oxandrolone—AR—Generic Transcription Pathway—MYC—hematologic cancer	2.25e-05	0.000384	CbGpPWpGaD
Oxandrolone—AR—Gene Expression—MAPK14—hematologic cancer	2.12e-05	0.000363	CbGpPWpGaD
Oxandrolone—AR—Gene Expression—ESR1—hematologic cancer	2.08e-05	0.000356	CbGpPWpGaD
Oxandrolone—AR—Gene Expression—NOTCH1—hematologic cancer	2.01e-05	0.000344	CbGpPWpGaD
Oxandrolone—AR—Gene Expression—CREBBP—hematologic cancer	1.82e-05	0.000312	CbGpPWpGaD
Oxandrolone—AR—Gene Expression—MAPK3—hematologic cancer	1.11e-05	0.00019	CbGpPWpGaD
Oxandrolone—AR—Gene Expression—MYC—hematologic cancer	1.08e-05	0.000185	CbGpPWpGaD
Oxandrolone—AR—Gene Expression—AKT1—hematologic cancer	7.5e-06	0.000128	CbGpPWpGaD
